ATC code L01
Abdominal pain
Abemaciclib
Acalabrutinib
Acute kidney injury
Adagrasib
Adverse effect
Afatinib
Aflibercept
Alectinib
Alemtuzumab
Alpelisib
American Society of Health-System Pharmacists
Amivantamab
Anaplastic lymphoma kinase
Anatomical Therapeutic Chemical Classification System
Anemia
Antineoplastic
Asciminib
Atezolizumab
Aumolertinib
Avapritinib
Avelumab
Axatilimab
Axitinib
BRAF (gene)
Baricitinib
Belantamab mafodotin
Bermekimab
Bevacizumab
Binimetinib
Blinatumomab
Bosutinib
Breast cancer
Brentuximab vedotin
Brigatinib
Bruton's tyrosine kinase
CAS Registry Number
CD135
CD20
CD30
CD33
CD3 (immunology)
CD52
CDK inhibitor
Cabozantinib
Cancer immunotherapy
Capmatinib
Carboplatin
Carcinoma
Catumaxomab
Cediranib
Cemiplimab
Ceritinib
Cetuximab
Chemical formula
Cisplatin
Cobimetinib
Colorectal cancer
Copanlisib
Cosibelimab
Crizotinib
Cyst
Dabrafenib
Dacomitinib
DailyMed
Dalpiciclib
Daratumumab
Dasatinib
Denileukin diftitox
Doi (identifier)
Durvalumab
Duvelisib
EML4
Edrecolomab
Elotuzumab
Elranatamab
Encorafenib
Enfortumab vedotin
Entrectinib
Epcoritamab
Epidermal growth factor receptor
ErbB
Erdafitinib
Erlotinib
Everolimus
Exotoxin
Fedratinib
Fever
Fibroblast growth factor receptor
Filgotinib
Food and Drug Administration
Fruquintinib
Fusion protein
Futibatinib
Gefitinib
Gemtuzumab ozogamicin
Gilteritinib
Glasdegib
Glofitamab
Half-life
Hdl (identifier)
Hedgehog signaling pathway
ISSN (identifier)
Ibritumomab tiuxetan
Ibrutinib
Icotinib
Idelalisib
Imatinib
Immune system
Immunosuppression
Inavolisib
Infigratinib
Inotuzumab ozogamicin
Interleukin 2
Ipilimumab
Isatuximab
Janus kinase
KRAS
Lapatinib
Medicaid
Molar mass
PMC (identifier)
PMID (identifier)
Public domain
S2CID (identifier)